Epidemiology of urological infections: a global burden.

Öztürk R., Murt A.

World journal of urology, cilt.38, ss.2669-2679, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 38
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1007/s00345-019-03071-4
  • Dergi Adı: World journal of urology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, Gender Studies Database, MEDLINE
  • Sayfa Sayıları: ss.2669-2679
  • Anahtar Kelimeler: Community-acquired urinary tract infection, Community-onset healthcare-associated urinary tract infection, Epidemiology, Global burden, Healthcare-associated urinary tract infection, Urological infections, URINARY-TRACT-INFECTIONS, QUALITY-OF-LIFE, ASYMPTOMATIC BACTERIURIA, RISK-FACTORS, AMERICA GUIDELINES, ESCHERICHIA-COLI, DISEASES-SOCIETY, RESOURCE USE, TRENDS, PREVALENCE
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Introduction Urinary tract infections (UTIs) are among the most frequent infections in clinical practice worldwide. Their frequency and burden must be higher than available data suggest because they are not among mandatory diseases to be notified. Classification of urinary infections Although there are many different proposals for classifying UTIs, classifications based on acquisition settings and complication status are more widely used. These include community- acquired UTIs (CAUTIs) or healthcare-associated UTIs (HAUTIs) and uncomplicated or complicated UTIs. Epidemiology of urological infections and global burden As the most frequently seen infectious disease, CAUTIs affect more than 150 million people annually. Complicated UTIs in particular constitute a huge burden on healthcare systems as a frequent reason for hospitalization. The prevalence of HAUTIs ranges between 1.4% and 5.1%, and the majority of them are catheter-related UTIs. Community-onset HAUTIs have gained importance in recent years. Conclusion As frequent infectious diseases, UTIs create clinical and economic burdens on healthcare systems, and they also affect quality of life determinants.